Passage Bio, Inc. (PASG)

Passage Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	36.77	21.71	34.6	128.97	135	158.87
Short-Term Investments	67.75	92.59	155.01	186.81	169.82	0
Cash & Cash Equivalents	104.53	114.29	189.61	315.77	304.82	158.87
Cash Growth	-37.70%	-39.72%	-39.95%	3.59%	91.86%	539.05%
Other Current Assets	3.77	3.67	7.43	9.29	12.37	6.9
Total Current Assets	108.29	117.96	197.04	325.07	317.18	165.78
Property, Plant & Equipment	31.58	32.15	42.24	23.81	2.8	1.09
Other Long-Term Assets	0.66	0.43	4.27	6.2	8.03	11.75
Total Long-Term Assets	32.24	32.59	46.51	30.01	10.82	12.84
Total Assets	140.53	150.55	243.55	355.08	328.01	178.61
Accounts Payable	1.69	1.3	4.07	9.45	5.27	0.63
Current Debt	3.67	3.37	3.28	0	0	0
Other Current Liabilities	7.48	11.67	11.01	20.05	15.91	3.05
Total Current Liabilities	12.84	16.34	18.35	29.5	21.18	3.68
Long-Term Debt	22.81	22.92	23.83	0	0	0
Other Long-Term Liabilities	0	0	0	6.92	2.12	0.58
Total Long-Term Liabilities	22.81	22.92	23.83	6.92	2.12	0.58
Total Liabilities	35.65	39.26	42.18	36.42	23.29	4.26
Total Debt	26.48	26.29	27.11	0	0	0
Debt Growth	-1.76%	-3.00%	-	-	-	-
Retained Earnings	-611.18	-594.47	-492.41	-356.28	-170.9	-58.66
Comprehensive Income	-0.07	-0.04	-0.97	-0.41	-0.01	0
Shareholders' Equity	104.88	111.28	201.37	318.66	304.71	-56.25
Net Cash / Debt	78.05	88	162.5	315.77	304.82	158.87
Net Cash / Debt Growth	-44.58%	-45.85%	-48.54%	3.59%	91.86%	539.05%
Net Cash Per Share	1.39	1.61	2.99	5.92	7.89	37.51
Working Capital	95.45	101.62	178.69	295.57	296.01	162.09
Book Value Per Share	1.86	2.03	3.70	5.97	7.89	-13.28

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).